Karl Morten

4.3k total citations · 1 hit paper
83 papers, 3.0k citations indexed

About

Karl Morten is a scholar working on Molecular Biology, Clinical Biochemistry and Epidemiology. According to data from OpenAlex, Karl Morten has authored 83 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 18 papers in Clinical Biochemistry and 11 papers in Epidemiology. Recurrent topics in Karl Morten's work include Mitochondrial Function and Pathology (33 papers), Metabolism and Genetic Disorders (18 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (9 papers). Karl Morten is often cited by papers focused on Mitochondrial Function and Pathology (33 papers), Metabolism and Genetic Disorders (18 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (9 papers). Karl Morten collaborates with scholars based in United Kingdom, Poland and United States. Karl Morten's co-authors include Joanna Poulton, Emma Newport, Michelle Potter, Garry K. Brown, Laurence A. Bindoff, Benedikt M. Kessler, Anna Katharina Simon, Masaaki Komatsu, David Ferguson and Mariola J. Edelmann and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Karl Morten

81 papers receiving 3.0k citations

Hit Papers

Long COVID: mechanisms, risk factors and recovery 2022 2026 2023 2024 2022 40 80 120
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Long COVID: mechanisms, risk factors and recovery
    2022 120 citations Karl Morten, Etheresia Pretorius et al. profile →

Peers

Karl Morten
Juan R. Vinã Spain
Tom J. de Koning Netherlands
Fumio Endo Japan
Michel van Weeghel Netherlands
María Alexandra Brito Portugal
Anthony Molina United States
Satoshi Ogawa Japan
José Marı́n-Garcı́a United States
Juan R. Vinã Spain
Karl Morten
Citations per year, relative to Karl Morten Karl Morten (= 1×) peers Juan R. Vinã

Countries citing papers authored by Karl Morten

Since Specialization
Citations

This map shows the geographic impact of Karl Morten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Morten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Morten more than expected).

Fields of papers citing papers by Karl Morten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl Morten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Morten. The network helps show where Karl Morten may publish in the future.

Co-authorship network of co-authors of Karl Morten

This figure shows the co-authorship network connecting the top 25 collaborators of Karl Morten. A scholar is included among the top collaborators of Karl Morten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl Morten. Karl Morten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Woodward, Mark, Jianrong He, Tim Waterboer, et al.. (2025). First trimester maternal infections and offspring congenital heart defects: a meta-analysis. European Heart Journal. 47(7). 794–812. 1 indexed citations
2.
Higgs, Martin R., A Snaith, Sławomir Kujawski, et al.. (2025). Dysregulation of lipid metabolism, energy production, and oxidative stress in myalgic encephalomyelitis/chronic fatigue syndrome, Gulf War Syndrome and fibromyalgia. Frontiers in Neuroscience. 19. 1498981–1498981. 2 indexed citations
3.
Xu, Jiabao & Karl Morten. (2024). Raman micro-spectroscopy as a tool to study immunometabolism. Biochemical Society Transactions. 52(2). 733–745. 9 indexed citations
4.
Kandžija, Neva, Sarah Hutchinson, Wei Zhang, et al.. (2023). Using isolated mitochondria to improve placental bioenergetics: A potential treatment for Fetal Growth Restriction (FGR). Placenta. 140. e18–e18.
5.
Morten, Karl, et al.. (2021). Induced pluripotent stem cells as suitable sensors for fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome. World Journal of Stem Cells. 13(8). 1134–1150. 5 indexed citations
6.
Smith, David A., Claire Smith, Lauren Morris, et al.. (2020). Acetyl-leucine slows disease progression in lysosomal storage disorders. Brain Communications. 3(1). fcaa148–fcaa148. 40 indexed citations
7.
Tomas, Cara, et al.. (2019). Assessing cellular energy dysfunction in CFS/ME using a commercially available laboratory test. Scientific Reports. 9(1). 11464–11464. 10 indexed citations
8.
Nguyen, Xuan, et al.. (2018). Development of a microfluidic perfusion 3D cell culture system. Journal of Micromechanics and Microengineering. 28(4). 45001–45001. 9 indexed citations
9.
Agnew, Thomas, Michelle Goldsworthy, Carlos Aguilar, et al.. (2018). A Wars2 Mutant Mouse Model Displays OXPHOS Deficiencies and Activation of Tissue-Specific Stress Response Pathways. Cell Reports. 25(12). 3315–3328.e6. 32 indexed citations
10.
11.
Rapa, Elizabeth, et al.. (2012). The over-expression of cell migratory genes in alveolar rhabdomyosarcoma could contribute to metastatic spread. Clinical & Experimental Metastasis. 29(5). 419–429. 14 indexed citations
12.
Roy, Debashis, et al.. (2009). MITOCHONDRIAL FUNCTION DURING ISCHAEMIA-REPERFUSION IN DCD LIVERS. Transplant International. 22. 39–39. 2 indexed citations
13.
Roy, Debashis, et al.. (2009). MITOCHONDRIAL PROTECTION BY OXYGENATED PERFUSION AFTER WARM ISCHAEMIA. Transplant International. 22. 55–55. 3 indexed citations
14.
Ashley, Neil, Sandeep Jayawant, Jeremy Parr, et al.. (2007). Mutations in the mitochondrial DNA gamma polymerase (POLG-G) may cause Alpers syndrome, mitochondrial DNA depletion and apparent non-syndromic status epilepticus: implications for valproate therapy. Journal of Medical Genetics. 44. 1 indexed citations
15.
Fratter, Carl, A O'Rourke, Jackie Marchington, et al.. (2006). Molecular genetic diagnosis of mitochondrial DNA depletion syndrome and Alpers syndrome. Journal of Medical Genetics. 43. 1 indexed citations
16.
Morten, Karl, Neil Ashley, Kenneth Williams, et al.. (2005). Fetal and neonatal exposure to AZT and low-protein diet affects glucose homeostasis: a model with implications for AIDS prevention. American Journal of Physiology-Endocrinology and Metabolism. 289(6). E1115–E1118. 5 indexed citations
17.
Black, Graeme C., et al.. (1996). Leber's hereditary Optic neuropathy:heteroplasmy is likely ot be significant in the expression of LHON in families with the 3460 ND1 mutation. Journal of Ophthalmology. 80. 1 indexed citations
18.
Poulton, Joanna, et al.. (1995). Mitochondrial DNA, diabetes and pancreatic pathology in Kearns-Sayre syndrome. Diabetologia. 38(7). 868–871. 48 indexed citations
19.
Morten, Karl, Jonathan M. Cooper, Garry K. Brown, et al.. (1993). A new point mutation associated with mitochondrial encephalomyopathy. Human Molecular Genetics. 2(12). 2081–2087. 85 indexed citations
20.
Morten, Karl, et al.. (1992). Changes in double-stranded RNA profiles inAgaricus bisporusduring subculture. FEMS Microbiology Letters. 91(2). 159–163. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juan R. Vinã Breakdown of academic impact, for papers by Tom J. de Koning Breakdown of academic impact, for papers by Fumio Endo Breakdown of academic impact, for papers by Michel van Weeghel Breakdown of academic impact, for papers by María Alexandra Brito Breakdown of academic impact, for papers by Anthony Molina Breakdown of academic impact, for papers by Satoshi Ogawa Breakdown of academic impact, for papers by José Marı́n-Garcı́a
Rankless by CCL
2026